French Glendon E. III's Form 4 filing
Pulmonx Corp (LUNG) · filed Jan 21, 2025
- Accession no.
- 0001415889-25-001819
- Filed
- Jan 21, 2025
- Trade date
- Jan 16-17, 2025
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $29.6K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| French Glendon E. IIICIK 0001805624 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 16, 2025 | Common Stock | SSaleDisposed | −2,326 | $6.53 | −$15,188.78 | 1,069,648 | Direct | |
| Jan 17, 2025 | Common Stock | SSaleDisposed | −2,221 | $6.50 | −$14,436.5 | 1,067,427 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.